全部| 求助中| 待确认 按时间排序|按积分排序

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

用户r-lcVIN14xaE 1个月前 50 已关闭

PerC B‐Cells Activation via Thermogenetics‐Based CXCL12 Generator for Intraperitoneal Immunity Against Metastatic Disseminated Tumor Cells

用户L3OTDduPo8Hc 1个月前 10 已完结

Large-Scale Cell Production Based on GMP-Grade Dissolvable Porous Microcarriers

用户L3OTDduPo8Hc 1个月前 10 已完结

Repeated Temperature Fluctuation Exposure Causes Prolonged Skin Barrier Dysfunction

用户Mp9ryMXiT0kM 1个月前 10 已完结

… 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group

用户01teaJT8fXjY 1个月前 10 已完结

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

乔垣结衣 1个月前 50 已完结

S-acylation of ATGL is required for lipid droplet homoeostasis in hepatocytes

用户L3OTDduPo8Hc 1个月前 10 已完结

PILRα on tumor cells interacts with the T cell surface protein CD99 to suppress antitumor immunity

用户VOn592q4vVUg 1个月前 10 已关闭

Schiff-base crosslinked gelatin-mycosporine-like amino acids/dialdehyde starch composite film: a UV-resistant, biodegradable food packaging material

用户dbCTygZHmbuY 1个月前 10 已完结

A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals

用户__dVOd073hsc 1个月前 10 已完结
首页 上页 96 97 98 99 100 下页

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com